https://www.marketscreener.com/quote/stock/PHIO-PHARMACEUTICALS-CORP-47281669/news/Phio-Pharmaceuticals-Corp-Announces-First-US-Patient-Enrolled-in-Phase-1B-Clinical-Trial-with-Intra-45293612/?utm_source=telegram&utm_medium=social&utm_campaign=share